Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Continuing Appropriations Amendments Act, 2018
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support for passage of H.R. 1301, FY17 Defense Appropriations Bill
Continuing Appropriations Amendments Act, 2018
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support passage of H.R. 1301, FY17 Defense Appropriations Bill
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2019 · fourth_quarter · 4T
Support for increased funding for the NIH/NCI within the Labor, Health & Human Services appropriations bill
Support for funding for kidney cancer research within the DoD and Labor, HHS appropriations process.
Source: Senate LDA
Continuing Appropriations Amendments Act, 2018
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support passage of H.R. 1301, FY17 Defense Appropriations Bill
Continuing Appropriations Amendments Act, 2018
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support for passage of H.R. 1301, FY17 Defense Appropriations Bill
Patient Advocacy Transparency Act
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support of passage of FY 18 Appropriations legislation. S. 3000
Patient Advocacy Transparency Act
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
DEPARTMENT OF DEFENSE APPROPRIATIONS BILL, 2017 S. 3000 Support for inclusion of $10 million for Kidney Cancer Research program pursuant to the CDMRP (Congressionally Directed Medical Research Program) under the Defense Health Program.
Patient Advocacy Transparency Act
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
Support of passage of FY 18 Appropriations legislation. S. 3000
Patient Advocacy Transparency Act
Client: ACKC, ACTION TO CURE KIDNEY CANCER · Firm: VERITAS, LLC
DEPARTMENT OF DEFENSE APPROPRIATIONS BILL, 2017 S. 3000 Support for inclusion of $10 million for Kidney Cancer Research program pursuant to the CDMRP (Congressionally Directed Medical Research Program) under the Defense Health Program.
Support for the inclusion of kidney cancer research funding within the Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2019 · third_quarter · Q3
Support for increased funding for the NIH/NCI within the Labor, Health & Human Services appropriations bill
Support for the inclusion of kidney cancer research funding within the Defense Appropriations bill
Support for funding for kidney cancer research within the DoD and Labor, HHS appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2019 · second_quarter · Q2
Support for funding for kidney cancer research within the DoD and Labor, HHS appropriations process.
Support for increased funding for the NIH/NCI within the Labor, Health & Human Services appropriations bill
Support for the inclusion of kidney cancer research funding within the Defense Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2019 · first_quarter · Q1
Support for the inclusion of kidney cancer research funding within the Defense Appropriations bill
Support for funding for kidney cancer research within the DoD and Labor, HHS appropriations process.
Support for increased funding for the NIH/NCI within the Labor, Health & Human Services appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2018 · fourth_quarter · Q4
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Support for CDMRP funding in FY 2019 Appropriations
Support for FY 19 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 19 National Institutes of Health increased funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2018 · third_quarter · Q3
Support for FY 19 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 19 National Institutes of Health increased funding.
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Support for CDMRP funding in FY 2019 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2018 · second_quarter · Q2
Support for CDMRP funding in FY 2019 Appropriations
Support for FY 19 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 19 National Institutes of Health increased funding.
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2018 · first_quarter · Q1
Support for CDMRP funding in FY 2018 Appropriations
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Support for FY 18 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 18 National Institutes of Health increased funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · fourth_quarter · 4A
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Support for CDMRP funding in FY 2018 Appropriations
Support for FY 18 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 18 National Institutes of Health increased funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · third_quarter · 3A
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Support for FY 18 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 18 National Institutes of Health increased funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · third_quarter · Q3
DEPARTMENT OF DEFENSE APPROPRIATIONS BILL, 2017 S. 3000 Support for inclusion of $10 million for Kidney Cancer Research program pursuant to the CDMRP (Congressionally Directed Medical Research Program) under the Defense Health Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · second_quarter · Q2
Education and awareness of kidney cancer. Information gathering and advocacy regarding the FY2018 Defense Appropriations planning, budgeting regarding the Congressionally Directed Medical Research Program. Information gathering and advocacy regarding the FY2018 Health, Education, Labor, Pensions Appropriations planning, budgeting regarding the funding for the National Institutes of Health (NIH).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · second_quarter · Q2
Support for passage of H.R. 1301, FY17 Defense Appropriations Bill
Support passage of H.R. 1301, FY17 Defense Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · third_quarter · RA
Support for FY 18 Defense Appropriations - CDMRP Support for increased NIH funding
Support for FY 18 Defense Appropriations - CDMRP Support for increased NIH funding
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · first_quarter · RA
Support of passage of FY 18 Appropriations legislation. S. 3000
Support of passage of FY 18 Appropriations legislation. S. 3000
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · third_quarter · Q3
Support for FY 18 Department of Defense Appropriations for CDMRP/KCRP. Support for FY 18 National Institutes of Health increased funding.
Support for FY 18 Department of Defense Appropriations, CDMRP/KCRP Support for increased funding for the National Institutes of Health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · third_quarter · 3T
DEPARTMENT OF DEFENSE APPROPRIATIONS BILL, 2017 S. 3000 Support for inclusion of $10 million for Kidney Cancer Research program pursuant to the CDMRP (Congressionally Directed Medical Research Program) under the Defense Health Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CANCER ACTION NETWORK via VERITAS, LLC
2017 · third_quarter · RR
CDMRP funding, Department of Defense National Institutes of Health, National Cancer Institute CDC
CDMRP funding, Department of Defense National Institutes of Health, National Cancer Institute CDC
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · first_quarter · Q1
Support passage of H.R. 1301, FY17 Defense Appropriations Bill
Support for passage of H.R. 1301, FY17 Defense Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACKC, ACTION TO CURE KIDNEY CANCER via VERITAS, LLC
2017 · first_quarter · RR
Appropriations for FY 17 and FY18. Passage of an omnibus or Defense Appropriations bill as opposed to a continuing resolution.
Appropriations for FY 17 and FY18. Passage of an omnibus or Defense Appropriations bill as opposed to a continuing resolution.
Appropriations for FY 17 and FY18. Passage of an omnibus or Defense Appropriations bill as opposed to a continuing resolution.
Appropriations for FY 17 and FY18. Passage of an omnibus or Defense Appropriations bill as opposed to a continuing resolution.